{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T03:34:12Z","timestamp":1758944052409,"version":"3.41.0"},"reference-count":135,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2016,7,27]],"date-time":"2016-07-27T00:00:00Z","timestamp":1469577600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100012389","name":"RayBiotech 2013 Innovative Research Grant Award","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100012389","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Tumor Biol."],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1007\/s13277-016-5198-4","type":"journal-article","created":{"date-parts":[[2016,7,27]],"date-time":"2016-07-27T12:08:10Z","timestamp":1469621290000},"page":"13005-13016","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Mechanisms underlying the association between obesity and Hodgkin lymphoma"],"prefix":"10.1007","volume":"37","author":[{"given":"Andreia","family":"Matos","sequence":"first","affiliation":[]},{"given":"Joana","family":"Marinho-Dias","sequence":"additional","affiliation":[]},{"given":"Sofia","family":"Ramalheira","sequence":"additional","affiliation":[]},{"given":"Maria Jos\u00e9","family":"Oliveira","sequence":"additional","affiliation":[]},{"given":"Manuel","family":"Bicho","sequence":"additional","affiliation":[]},{"given":"Ricardo","family":"Ribeiro","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2016,7,27]]},"reference":[{"key":"5198_CR1","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/35007508","volume":"404","author":"PG Kopelman","year":"2000","unstructured":"Kopelman PG. Obesity as a medical problem. Nature. 2000;404:635\u201343.","journal-title":"Nature"},{"key":"5198_CR2","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.beem.2013.04.005","volume":"27","author":"H Boeing","year":"2013","unstructured":"Boeing H. Obesity and cancer\u2014the update 2013. Best Pract Res Clin Endocrinol Metab. 2013;27:219\u201327.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"5198_CR3","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/j.bbalip.2013.02.008","volume":"1831","author":"SM Louie","year":"2013","unstructured":"Louie SM, Roberts LS, Nomura DK. Mechanisms linking obesity and cancer. Biochim Biophys Acta. 2013;1831:1499\u2013508.","journal-title":"Biochim Biophys Acta"},{"key":"5198_CR4","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1016\/j.ejca.2011.06.029","volume":"47","author":"SC Larsson","year":"2011","unstructured":"Larsson SC, Wolk A. Body mass index and risk of non-Hodgkin\u2019s and Hodgkin\u2019s lymphoma: a meta-analysis of prospective studies. Eur J Cancer. 2011;47:2422\u201330.","journal-title":"Eur J Cancer"},{"key":"5198_CR5","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1038\/bjc.2013.159","volume":"108","author":"F Murphy","year":"2013","unstructured":"Murphy F, Kroll ME, Pirie K, Reeves G, Green J, Beral V. Body size in relation to incidence of subtypes of haematological malignancy in the prospective Million Women Study. Br J Cancer. 2013;108:2390\u20138.","journal-title":"Br J Cancer"},{"key":"5198_CR6","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/path.2711","volume":"221","author":"D Aldinucci","year":"2010","unstructured":"Aldinucci D, Gloghini A, Pinto A, De Filippi R, Carbone A. The classical Hodgkin\u2019s lymphoma microenvironment and its role in promoting tumour growth and immune escape. J Pathol. 2010;221:248\u201363.","journal-title":"J Pathol"},{"key":"5198_CR7","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/nrc2542","volume":"9","author":"R K\u00fcppers","year":"2009","unstructured":"K\u00fcppers R. The biology of Hodgkin\u2019s lymphoma. Nat Rev Cancer. 2009;9:15\u201327.","journal-title":"Nat Rev Cancer"},{"key":"5198_CR8","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1002\/ajh.24272","volume":"91","author":"SM Ansell","year":"2016","unstructured":"Ansell SM. Hodgkin lymphoma: 2016 update on diagnosis, risk-stratification, and management. Am J Hematol. 2016;91:434\u201342.","journal-title":"Am J Hematol"},{"key":"5198_CR9","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S1470-2045(03)01320-2","volume":"5","author":"V Diehl","year":"2004","unstructured":"Diehl V, Thomas RK, D R. Part II: Hodgkin\u2019s lymphoma\u2014diagnosis and treatment. Lancet Oncol. 2004;5:19\u201326.","journal-title":"Lancet Oncol"},{"key":"5198_CR10","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1200\/JCO.2013.53.1194","volume":"32","author":"GP Canellos","year":"2014","unstructured":"Canellos GP, Rosenberg SA, Friedberg JW, Lister TA, Devita VT. Treatment of Hodgkin lymphoma: a 50-year perspective. Journal of clinical oncology: official journal of the American Society of Clinical Oncology. 2014;32:163\u20138.","journal-title":"Journal of clinical oncology: official journal of the American Society of Clinical Oncology"},{"key":"5198_CR11","doi-asserted-by":"crossref","first-page":"3547","DOI":"10.1182\/blood-2012-09-454694","volume":"121","author":"JA Kanakry","year":"2013","unstructured":"Kanakry JA, Li H, Gellert LL, Lemas MV, Hsieh WS, Hong F, Tan KL, Gascoyne RD, Gordon LI, Fisher RI, et al. Plasma Epstein-Barr virus DNA predicts outcome in advanced Hodgkin lymphoma: correlative analysis from a large North American cooperative group trial. Blood. 2013;121:3547\u201353.","journal-title":"Blood"},{"key":"5198_CR12","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1056\/NEJM199811193392104","volume":"339","author":"D Hasenclever","year":"1998","unstructured":"Hasenclever D, Diehl V. A prognostic score for advanced Hodgkin\u2019s disease. International Prognostic Factors Project on Advanced Hodgkin\u2019s Disease. N Engl J Med. 1998;339:1506\u201314.","journal-title":"N Engl J Med"},{"key":"5198_CR13","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1200\/JCO.2010.32.8401","volume":"29","author":"C Steidl","year":"2011","unstructured":"Steidl C, Connors JM, Gascoyne RD. Molecular pathogenesis of Hodgkin\u2019s lymphoma: increasing evidence of the importance of the microenvironment. Journal of clinical oncology: official journal of the American Society of Clinical Oncology. 2011;29:1812\u201326.","journal-title":"Journal of clinical oncology: official journal of the American Society of Clinical Oncology"},{"key":"5198_CR14","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1159\/000115365","volume":"36","author":"RS Ahima","year":"2008","unstructured":"Ahima RS, Osei SY. Adipokines in obesity. Front Horm Res. 2008;36:182\u201397.","journal-title":"Front Horm Res"},{"key":"5198_CR15","doi-asserted-by":"crossref","first-page":"6974","DOI":"10.1158\/1078-0432.CCR-08-1026","volume":"14","author":"RJ Biggar","year":"2008","unstructured":"Biggar RJ, Johansen JS, Smedby KE, Rostgaard K, Chang ET, Adami HO, Glimelius B, Molin D, Hamilton-Dutoit S, Melbye M, et al. Serum YKL-40 and interleukin 6 levels in Hodgkin lymphoma. Clin Cancer Res. 2008;14:6974\u20138.","journal-title":"Clin Cancer Res"},{"key":"5198_CR16","doi-asserted-by":"crossref","first-page":"3216","DOI":"10.1182\/blood-2003-08-2860","volume":"103","author":"W Cozen","year":"2004","unstructured":"Cozen W, Gill PS, Ingles SA, Masood R, Mart\u00ednez-Maza O, Cockburn MG, Gauderman WJ, Pike MC, Bernstein L, Nathwani BN, et al. IL-6 levels and genotype are associated with risk of young adult Hodgkin lymphoma. Blood. 2004;103:3216\u201321.","journal-title":"Blood"},{"key":"5198_CR17","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/j.leukres.2009.01.009","volume":"33","author":"S Hohaus","year":"2009","unstructured":"Hohaus S, Giachelia M, Massini G, Vannata B, Criscuolo M, Martini M, D\u2019Alo F, Voso MT, Larocca LM, Leone G. Clinical significance of interleukin-10 gene polymorphisms and plasma levels in Hodgkin lymphoma. Leuk Res. 2009;33:1352\u20136.","journal-title":"Leuk Res"},{"key":"5198_CR18","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nature08099","volume":"460","author":"O Naveiras","year":"2009","unstructured":"Naveiras O, Nardi V, Wenzel PL, Hauschka PV, Fahey F, Daley GQ. Bone-marrow adipocytes as negative regulators of the haematopoietic microenvironment. Nature. 2009;460:259\u201363.","journal-title":"Nature"},{"key":"5198_CR19","first-page":"21","volume":"3","author":"D Okwan-Duodu","year":"2013","unstructured":"Okwan-Duodu D, Umpierrez GE, Brawley OW, Diaz R. Obesity-driven inflammation and cancer risk: role of myeloid derived suppressor cells and alternately activated macrophages. Am J Cancer Res. 2013;3:21\u201333.","journal-title":"Am J Cancer Res"},{"key":"5198_CR20","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.leukres.2013.03.021","volume":"37","author":"C Casulo","year":"2013","unstructured":"Casulo C, Arcila M, Bohn OL, Teruya-Feldstein J, Maragulia J, Moskowitz CH. Tumor associated macrophages in relapsed and refractory Hodgkin lymphoma. Leuk Res. 2013;37:1178\u201383.","journal-title":"Leuk Res"},{"key":"5198_CR21","first-page":"756353","volume":"2012","author":"Cruz-Merino L de la","year":"2012","unstructured":"de la Cruz-Merino L, Lejeune M, Nogales Fernandez E, Henao Carrasco F, Grueso Lopez A, Illescas Vacas A, Pulla MP, Callau C, Alvaro T. Role of immune escape mechanisms in Hodgkin\u2019s lymphoma development and progression: a whole new world with therapeutic implications. Clin Dev Immunol. 2012;2012:756353.","journal-title":"Clin Dev Immunol"},{"key":"5198_CR22","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.semcancer.2013.07.002","volume":"24","author":"Y Liu","year":"2014","unstructured":"Liu Y, Sattarzadeh A, Diepstra A, Visser L, van den Berg A. The microenvironment in classical Hodgkin lymphoma: an actively shaped and essential tumor component. Semin Cancer Biol. 2014;24:15\u201322.","journal-title":"Semin Cancer Biol"},{"key":"5198_CR23","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1182\/asheducation.V2012.1.328.3798326","volume":"2012","author":"R Kuppers","year":"2012","unstructured":"Kuppers R. New insights in the biology of Hodgkin lymphoma. Hematology Am Soc Hematol Educ Program. 2012;2012:328\u201334.","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"5198_CR24","doi-asserted-by":"crossref","unstructured":"Ostrand-Rosenberg S. Immune surveillance: a balance between protumor and antitumor immunity. Current opinion in genetics & development. 2008;18:11\u20138.","DOI":"10.1016\/j.gde.2007.12.007"},{"issue":"Suppl 1","key":"5198_CR25","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1093\/annonc\/13.S1.52","volume":"13","author":"E Maggio","year":"2002","unstructured":"Maggio E, van den Berg A, Diepstra A, Kluiver J, Visser L, Poppema S. Chemokines, cytokines and their receptors in Hodgkin\u2019s lymphoma cell lines and tissues. Annals of oncology: official journal of the European Society for Medical Oncology\/ESMO. 2002;13(Suppl 1):52\u20136.","journal-title":"Annals of oncology: official journal of the European Society for Medical Oncology\/ESMO"},{"key":"5198_CR26","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1172\/JCI61245","volume":"122","author":"R Kuppers","year":"2012","unstructured":"Kuppers R, Engert A, Hansmann ML. Hodgkin lymphoma. J Clin Invest. 2012;122:3439\u201347.","journal-title":"J Clin Invest"},{"key":"5198_CR27","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S0002-9440(10)64878-X","volume":"160","author":"D Aldinucci","year":"2002","unstructured":"Aldinucci D, Poletto D, Gloghini A, Nanni P, Degan M, Perin T, Ceolin P, Rossi FM, Gattei V, Carbone A, et al. Expression of functional interleukin-3 receptors on Hodgkin and Reed-Sternberg cells. Am J Pathol. 2002;160:585\u201396.","journal-title":"Am J Pathol"},{"key":"5198_CR28","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1136\/jcp.55.3.162","volume":"55","author":"SA Pileri","year":"2002","unstructured":"Pileri SA, Ascani S, Leoncini L, Sabattini E, Zinzani PL, Piccaluga PP, Pileri Jr A, Giunti M, Falini B, Bolis GB, et al. Hodgkin\u2019s lymphoma: the pathologist\u2019s viewpoint. J Clin Pathol. 2002;55:162\u201376.","journal-title":"J Clin Pathol"},{"key":"5198_CR29","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1007\/BF02982639","volume":"77","author":"IS Lee","year":"2003","unstructured":"Lee IS, Kim SH, Song HG, Park SH. The molecular basis for the generation of Hodgkin and Reed-Sternberg cells in Hodgkin\u2019s lymphoma. Int J Hematol. 2003;77:330\u20135.","journal-title":"Int J Hematol"},{"key":"5198_CR30","doi-asserted-by":"crossref","first-page":"787","DOI":"10.4049\/jimmunol.166.2.787","volume":"166","author":"HW Sohn","year":"2001","unstructured":"Sohn HW, Shin YK, Lee IS, Bae YM, Suh YH, Kim MK, Kim TJ, Jung KC, Park WS, Park CS, et al. CD99 regulates the transport of MHC class I molecules from the Golgi complex to the cell surface. Journal of immunology (Baltimore, Md: 1950). 2001;166:787\u201394.","journal-title":"Journal of immunology (Baltimore, Md: 1950)"},{"key":"5198_CR31","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1158\/1078-0432.CCR-12-2693","volume":"19","author":"K Jones","year":"2013","unstructured":"Jones K, Vari F, Keane C, Crooks P, Nourse JP, Seymour LA, Gottlieb D, Ritchie D, Gill D, Gandhi MK. Serum CD163 and TARC as disease response biomarkers in classical Hodgkin lymphoma. Clin Cancer Res. 2013;19:731\u201342.","journal-title":"Clin Cancer Res"},{"key":"5198_CR32","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1038\/labinvest.3700672","volume":"87","author":"J Wallentine","year":"2007","unstructured":"Wallentine J, Kim K, Seiler C, Vaughn C, Crockett D, Tripp S, Elenitoba-Johnson K, Lim M. Comprehensive identification of proteins in Hodgkin lymphoma-derived Reed-Sternberg cells by LC-MS\/MS. Lab Investig. 2007;87:1113\u201324.","journal-title":"Lab Investig"},{"key":"5198_CR33","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.3109\/10428194.2013.778405","volume":"54","author":"L Panico","year":"2013","unstructured":"Panico L, Ronconi F, Lepore M, Tenneriello V, Cantore N, Dell\u2019angelo AC, Ferbo U, Ferrara F. Prognostic role of tumor-associated macrophages and angiogenesis in classical Hodgkin lymphoma. Leukemia & lymphoma. 2013;54:2418\u201325.","journal-title":"Leukemia & lymphoma"},{"key":"5198_CR34","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/ijc.11370","volume":"107","author":"M Fischer","year":"2003","unstructured":"Fischer M, Juremalm M, Olsson N, Backlin C, Sundstrom C, Nilsson K, Enblad G, Nilsson G. Expression of CCL5\/RANTES by Hodgkin and Reed-Sternberg cells and its possible role in the recruitment of mast cells into lymphomatous tissue. International journal of cancer Journal international du cancer. 2003;107:197\u2013201.","journal-title":"International journal of cancer Journal international du cancer"},{"key":"5198_CR35","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1182\/blood.V94.6.2065","volume":"94","author":"F Jundt","year":"1999","unstructured":"Jundt F, Anagnostopoulos I, Bommert K, Emmerich F, Muller G, Foss HD, Royer HD, Stein H, Dorken B. Hodgkin\/Reed-Sternberg cells induce fibroblasts to secrete eotaxin, a potent chemoattractant for T cells and eosinophils. Blood. 1999;94:2065\u201371.","journal-title":"Blood"},{"key":"5198_CR36","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1532\/IJH97.06048","volume":"83","author":"MA Weniger","year":"2006","unstructured":"Weniger MA, Barth TF, Moller P. Genomic alterations in Hodgkin\u2019s lymphoma. Int J Hematol. 2006;83:379\u201384.","journal-title":"Int J Hematol"},{"key":"5198_CR37","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.cellsig.2005.05.010","volume":"18","author":"O Cochet","year":"2006","unstructured":"Cochet O, Frelin C, Peyron JF, Imbert V. Constitutive activation of STAT proteins in the HDLM-2 and L540 Hodgkin lymphoma-derived cell lines supports cell survival. Cell Signal. 2006;18:449\u201355.","journal-title":"Cell Signal"},{"key":"5198_CR38","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1084\/jem.191.2.207","volume":"191","author":"LM Staudt","year":"2000","unstructured":"Staudt LM. The molecular and cellular origins of Hodgkin\u2019s disease. J Exp Med. 2000;191:207\u201312.","journal-title":"J Exp Med"},{"key":"5198_CR39","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.1073\/pnas.0500613102","volume":"102","author":"PS Eis","year":"2005","unstructured":"Eis PS, Tam W, Sun L, Chadburn A, Li Z, Gomez MF, Lund E, Dahlberg JE. Accumulation of miR-155 and BIC RNA in human B cell lymphomas. Proc Natl Acad Sci U S A. 2005;102:3627\u201332.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5198_CR40","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/S0140-6736(14)60460-8","volume":"384","author":"M Ng","year":"2014","unstructured":"Ng M, Fleming T, Robinson M, Thomson B, Graetz N, Margono C, Mullany EC, Biryukov S, Abbafati C, Abera SF, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014;384:766\u201381.","journal-title":"Lancet"},{"key":"5198_CR41","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1056\/NEJMoa021423","volume":"348","author":"EE Calle","year":"2003","unstructured":"Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med. 2003;348:1625\u201338.","journal-title":"N Engl J Med"},{"key":"5198_CR42","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0140-6736(08)60269-X","volume":"371","author":"AG Renehan","year":"2008","unstructured":"Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet. 2008;371:569\u201378.","journal-title":"Lancet"},{"key":"5198_CR43","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1093\/aje\/kwj353","volume":"165","author":"A Engeland","year":"2007","unstructured":"Engeland A, Tretli S, Hansen S, Bjorge T. Height and body mass index and risk of lymphohematopoietic malignancies in two million Norwegian men and women. Am J Epidemiol. 2007;165:44\u201352.","journal-title":"Am J Epidemiol"},{"key":"5198_CR44","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1634\/theoncologist.2010-0206","volume":"15","author":"MA Lichtman","year":"2010","unstructured":"Lichtman MA. Obesity and the risk for a hematological malignancy: leukemia, lymphoma, or myeloma. Oncologist. 2010;15:1083\u2013101.","journal-title":"Oncologist"},{"key":"5198_CR45","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1023\/A:1008995217664","volume":"12","author":"A Wolk","year":"2001","unstructured":"Wolk A, Gridley G, Svensson M, Nyren O, McLaughlin JK, Fraumeni JF, Adam HO. A prospective study of obesity and cancer risk (Sweden). Cancer Causes Control. 2001;12:13\u201321.","journal-title":"Cancer Causes Control"},{"key":"5198_CR46","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1007\/s10552-006-0042-6","volume":"17","author":"E Willett","year":"2006","unstructured":"Willett E, Roman E. Obesity and the risk of Hodgkin lymphoma (United Kingdom). Cancer Causes Control. 2006;17:1103\u20136.","journal-title":"Cancer Causes Control"},{"key":"5198_CR47","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s10552-012-0100-1","volume":"24","author":"Q Li","year":"2013","unstructured":"Li Q, Chang ET, Bassig BA, Dai M, Qin Q, Gao Y, Zhang Y, Zheng T. Body size and risk of Hodgkin\u2019s lymphoma by age and gender: a population-based case-control study in Connecticut and Massachusetts. Cancer Causes Control. 2013;24:287\u201395.","journal-title":"Cancer Causes Control"},{"key":"5198_CR48","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/s10552-006-0023-9","volume":"17","author":"C Samanic","year":"2006","unstructured":"Samanic C, Chow WH, Gridley G, Jarvholm B, Fraumeni Jr JF. Relation of body mass index to cancer risk in 362,552 Swedish men. Cancer Causes Control. 2006;17:901\u20139.","journal-title":"Cancer Causes Control"},{"key":"5198_CR49","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1093\/annonc\/mdi145","volume":"16","author":"O Landgren","year":"2005","unstructured":"Landgren O, Andren H, Nilsson B, Ekbom A, Bjorkholm M. Risk profile and outcome in Hodgkin\u2019s lymphoma: is obesity beneficial? Annals of oncology: official journal of the European Society for Medical Oncology\/ESMO. 2005;16:838\u201340.","journal-title":"Annals of oncology: official journal of the European Society for Medical Oncology\/ESMO"},{"key":"5198_CR50","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/j.ejca.2008.11.004","volume":"45","author":"KC Soderberg","year":"2009","unstructured":"Soderberg KC, Kaprio J, Verkasalo PK, Pukkala E, Koskenvuo M, Lundqvist E, Feychting M. Overweight, obesity and risk of haematological malignancies: a cohort study of Swedish and Finnish twins. Eur J Cancer. 2009;45:1232\u20138.","journal-title":"Eur J Cancer"},{"key":"5198_CR51","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1093\/annonc\/mdt594","volume":"25","author":"F Hong","year":"2014","unstructured":"Hong F, Habermann TM, Gordon LI, Hochster H, Gascoyne RD, Morrison VA, Fisher RI, Bartlett NL, Stiff PJ, Cheson BD, et al. The role of body mass index in survival outcome for lymphoma patients: US intergroup experience. Annals of oncology: official journal of the European Society for Medical Oncology\/ESMO. 2014;25:669\u201374.","journal-title":"Annals of oncology: official journal of the European Society for Medical Oncology\/ESMO"},{"key":"5198_CR52","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1093\/jnci\/dji012","volume":"97","author":"ET Chang","year":"2005","unstructured":"Chang ET, Hjalgrim H, Smedby KE, Akerman M, Tani E, Johnsen HE, Glimelius B, Adami HO, Melbye M. Body mass index and risk of malignant lymphoma in Scandinavian men and women. J Natl Cancer Inst. 2005;97:210\u20138.","journal-title":"J Natl Cancer Inst"},{"key":"5198_CR53","doi-asserted-by":"crossref","first-page":"4742","DOI":"10.1200\/JCO.2005.11.726","volume":"23","author":"O SW","year":"2005","unstructured":"SW O, Yoon YS, Shin SA. Effects of excess weight on cancer incidences depending on cancer sites and histologic findings among men: Korea National Health Insurance Corporation Study. Journal of clinical oncology: official journal of the American Society of Clinical Oncology. 2005;23:4742\u201354.","journal-title":"Journal of clinical oncology: official journal of the American Society of Clinical Oncology"},{"key":"5198_CR54","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1093\/aje\/kwm122","volume":"166","author":"U Lim","year":"2007","unstructured":"Lim U, Morton LM, Subar AF, Baris D, Stolzenberg-Solomon R, Leitzmann M, Kipnis V, Mouw T, Carroll L, Schatzkin A, et al. Alcohol, smoking, and body size in relation to incident Hodgkin\u2019s and non-Hodgkin\u2019s lymphoma risk. Am J Epidemiol. 2007;166:697\u2013708.","journal-title":"Am J Epidemiol"},{"key":"5198_CR55","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1200\/JCO.2012.43.4589","volume":"31","author":"DW Scott","year":"2013","unstructured":"Scott DW, Chan FC, Hong F, Rogic S, Tan KL, Meissner B, Ben-Neriah S, Boyle M, Kridel R, Telenius A, et al. Gene expression-based model using formalin-fixed paraffin-embedded biopsies predicts overall survival in advanced-stage classical Hodgkin lymphoma. Journal of clinical oncology: official journal of the American Society of Clinical Oncology. 2013;31:692\u2013700.","journal-title":"Journal of clinical oncology: official journal of the American Society of Clinical Oncology"},{"key":"5198_CR56","doi-asserted-by":"crossref","first-page":"e87474","DOI":"10.1371\/journal.pone.0087474","volume":"9","author":"Z Liang","year":"2014","unstructured":"Liang Z, Diepstra A, Xu C, van Imhoff G, Plattel W, Van Den Berg A, Visser L. Insulin-like growth factor 1 receptor is a prognostic factor in classical Hodgkin lymphoma. PLoS One. 2014;9:e87474.","journal-title":"PLoS One"},{"key":"5198_CR57","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s10552-012-0136-2","volume":"24","author":"Y Gao","year":"2013","unstructured":"Gao Y, Li Q, Bassig BA, Chang ET, Dai M, Qin Q, Zhang Y, Zheng T. Subtype of dietary fat in relation to risk of Hodgkin lymphoma: a population-based case-control study in Connecticut and Massachusetts. Cancer Causes Control. 2013;24:485\u201394.","journal-title":"Cancer Causes Control"},{"key":"5198_CR58","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/ncpendmet1000","volume":"4","author":"A Romero-Corral","year":"2008","unstructured":"Romero-Corral A, Lopez-Jimenez F, Sierra-Johnson J, Somers VK. Differentiating between body fat and lean mass-how should we measure obesity? Nat Clin Pract Endocrinol Metab. 2008;4:322\u20133.","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"5198_CR59","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/ijo.2011.100","volume":"36","author":"J Gomez-Ambrosi","year":"2012","unstructured":"Gomez-Ambrosi J, Silva C, Galofre JC, Escalada J, Santos S, Millan D, Vila N, Ibanez P, Gil MJ, Valenti V, et al. Body mass index classification misses subjects with increased cardiometabolic risk factors related to elevated adiposity. International journal of obesity (2005). 2012;36:286\u201394.","journal-title":"International journal of obesity (2005)"},{"key":"5198_CR60","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1139\/apnm-2013-0360","volume":"39","author":"RA Murphy","year":"2014","unstructured":"Murphy RA, Bureyko TF, Miljkovic I, Cauley JA, Satterfield S, Hue TF, Klepin HD, Cummings SR, Newman AB, Harris TB. Association of total adiposity and computed tomographic measures of regional adiposity with incident cancer risk: a prospective population-based study of older adults. Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme. 2014;39:687\u201392.","journal-title":"Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme"},{"key":"5198_CR61","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1096\/fj.03-0591fje","volume":"18","author":"J Gomez-Ambrosi","year":"2004","unstructured":"Gomez-Ambrosi J, Catalan V, Diez-Caballero A, Martinez-Cruz LA, Gil MJ, Garcia-Foncillas J, Cienfuegos JA, Salvador J, Mato JM, Fruhbeck G. Gene expression profile of omental adipose tissue in human obesity. FASEB journal: official publication of the Federation of American Societies for Experimental Biology. 2004;18:215\u20137.","journal-title":"FASEB journal: official publication of the Federation of American Societies for Experimental Biology"},{"key":"5198_CR62","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1381\/0960892054222876","volume":"15","author":"A Baranova","year":"2005","unstructured":"Baranova A, Collantes R, Gowder SJ, Elariny H, Schlauch K, Younoszai A, King S, Randhawa M, Pusulury S, Alsheddi T, et al. Obesity-related differential gene expression in the visceral adipose tissue. Obes Surg. 2005;15:758\u201365.","journal-title":"Obes Surg"},{"key":"5198_CR63","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/1741-7015-10-108","volume":"10","author":"R Ribeiro","year":"2012","unstructured":"Ribeiro R, Monteiro C, Catalan V, Hu P, Cunha V, Rodriguez A, Gomez-Ambrosi J, Fraga A, Principe P, Lobato C, et al. Obesity and prostate cancer: gene expression signature of human periprostatic adipose tissue. BMC medicine. 2012;10:108.","journal-title":"BMC medicine"},{"key":"5198_CR64","doi-asserted-by":"crossref","first-page":"E827","DOI":"10.1152\/ajpendo.2001.280.6.E827","volume":"280","author":"G Fruhbeck","year":"2001","unstructured":"Fruhbeck G, Gomez-Ambrosi J, Muruzabal FJ, Burrell MA. The adipocyte: a model for integration of endocrine and metabolic signaling in energy metabolism regulation. Am J Phys Endocrinol Metab. 2001;280:E827\u201347.","journal-title":"Am J Phys Endocrinol Metab"},{"key":"5198_CR65","first-page":"233","volume":"55","author":"D Housa","year":"2006","unstructured":"Housa D, Housova J, Vernerova Z, Haluzik M. Adipocytokines and cancer. Physiological research\/Academia Scientiarum Bohemoslovaca. 2006;55:233\u201344.","journal-title":"Physiological research\/Academia Scientiarum Bohemoslovaca"},{"key":"5198_CR66","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1756-9966-31-32","volume":"31","author":"R Ribeiro","year":"2012","unstructured":"Ribeiro R, Monteiro C, Cunha V, Oliveira MJ, Freitas M, Fraga A, Principe P, Lobato C, Lobo F, Morais A, et al. Human periprostatic adipose tissue promotes prostate cancer aggressiveness in vitro. Journal of experimental & clinical cancer research: CR. 2012;31:32.","journal-title":"Journal of experimental & clinical cancer research: CR"},{"key":"5198_CR67","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1038\/sj.ijo.0802987","volume":"29","author":"JV Silha","year":"2005","unstructured":"Silha JV, Krsek M, Sucharda P, Murphy LJ. Angiogenic factors are elevated in overweight and obese individuals. Int J Obes. 2005;29:1308\u201314.","journal-title":"Int J Obes"},{"key":"5198_CR68","doi-asserted-by":"crossref","first-page":"3719","DOI":"10.1210\/jc.2007-0349","volume":"92","author":"J Gomez-Ambrosi","year":"2007","unstructured":"Gomez-Ambrosi J, Catalan V, Ramirez B, Rodriguez A, Colina I, Silva C, Rotellar F, Mugueta C, Gil MJ, Cienfuegos JA, et al. Plasma osteopontin levels and expression in adipose tissue are increased in obesity. J Clin Endocrinol Metab. 2007;92:3719\u201327.","journal-title":"J Clin Endocrinol Metab"},{"key":"5198_CR69","doi-asserted-by":"crossref","first-page":"E745","DOI":"10.1152\/ajpendo.2001.280.5.E745","volume":"280","author":"PA Kern","year":"2001","unstructured":"Kern PA, Ranganathan S, Li C, Wood L, Ranganathan G. Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am J Phys Endocrinol Metab. 2001;280:E745\u201351.","journal-title":"Am J Phys Endocrinol Metab"},{"key":"5198_CR70","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1016\/j.bbalip.2013.02.010","volume":"1831","author":"KM Nieman","year":"2013","unstructured":"Nieman KM, Romero IL, Van Houten B, Lengyel E. Adipose tissue and adipocytes support tumorigenesis and metastasis. Biochim Biophys Acta. 2013;1831:1533\u201341.","journal-title":"Biochim Biophys Acta"},{"key":"5198_CR71","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1210\/er.2010-0030","volume":"32","author":"J Park","year":"2011","unstructured":"Park J, Euhus DM, Scherer PE. Paracrine and endocrine effects of adipose tissue on cancer development and progression. Endocr Rev. 2011;32:550\u201370.","journal-title":"Endocr Rev"},{"key":"5198_CR72","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1002\/ijc.24389","volume":"125","author":"L Cattaruzza","year":"2009","unstructured":"Cattaruzza L, Gloghini A, Olivo K, Di Francia R, Lorenzon D, De Filippi R, Carbone A, Colombatti A, Pinto A, Aldinucci D. Functional coexpression of Interleukin (IL)-7 and its receptor (IL-7R) on Hodgkin and Reed-Sternberg cells: involvement of IL-7 in tumor cell growth and microenvironmental interactions of Hodgkin\u2019s lymphoma. International journal of cancer Journal international du cancer. 2009;125:1092\u2013101.","journal-title":"International journal of cancer Journal international du cancer"},{"key":"5198_CR73","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.leukres.2014.05.023","volume":"38","author":"C Marinaccio","year":"2014","unstructured":"Marinaccio C, Nico B, Maiorano E, Specchia G, Ribatti D. Insights in Hodgkin lymphoma angiogenesis. Leuk Res. 2014;38:857\u201361.","journal-title":"Leuk Res"},{"key":"5198_CR74","doi-asserted-by":"crossref","first-page":"720926","DOI":"10.4061\/2011\/720926","volume":"2011","author":"M Itoh","year":"2011","unstructured":"Itoh M, Suganami T, Hachiya R, Ogawa Y. Adipose tissue remodeling as homeostatic inflammation. Int J Inflam. 2011;2011:720926.","journal-title":"Int J Inflam"},{"key":"5198_CR75","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.cmet.2013.11.017","volume":"19","author":"SU Amano","year":"2014","unstructured":"Amano SU, Cohen JL, Vangala P, Tencerova M, Nicoloro SM, Yawe JC, Shen Y, Czech MP, Aouadi M. Local proliferation of macrophages contributes to obesity-associated adipose tissue inflammation. Cell Metab. 2014;19:162\u201371.","journal-title":"Cell Metab"},{"key":"5198_CR76","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s11626-013-9629-x","volume":"49","author":"SC Acedo","year":"2013","unstructured":"Acedo SC, Gambero S, Cunha FG, Lorand-Metze I, Gambero A. Participation of leptin in the determination of the macrophage phenotype: an additional role in adipocyte and macrophage crosstalk. In Vitro Cell Dev Biol Anim. 2013;49:473\u20138.","journal-title":"In Vitro Cell Dev Biol Anim"},{"key":"5198_CR77","doi-asserted-by":"crossref","first-page":"6153","DOI":"10.1074\/jbc.M109.088708","volume":"285","author":"K Ohashi","year":"2010","unstructured":"Ohashi K, Parker JL, Ouchi N, Higuchi A, Vita JA, Gokce N, Pedersen AA, Kalthoff C, Tullin S, Sams A, et al. Adiponectin promotes macrophage polarization toward an anti-inflammatory phenotype. J Biol Chem. 2010;285:6153\u201360.","journal-title":"J Biol Chem"},{"key":"5198_CR78","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1056\/NEJMoa0905680","volume":"362","author":"C Steidl","year":"2010","unstructured":"Steidl C, Lee T, Shah SP, Farinha P, Han G, Nayar T, Delaney A, Jones SJ, Iqbal J, Weisenburger DD, et al. Tumor-associated macrophages and survival in classic Hodgkin\u2019s lymphoma. N Engl J Med. 2010;362:875\u201385.","journal-title":"N Engl J Med"},{"key":"5198_CR79","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/pbc.22294","volume":"54","author":"ET Petridou","year":"2010","unstructured":"Petridou ET, Dessypris N, Panagopoulou P, Sergentanis TN, Mentis AF, Pourtsidis A, Polychronopoulou S, Kalmanti M, Athanasiadou-Piperopoulou F, Moschovi M. Adipocytokines in relation to Hodgkin lymphoma in children. Pediatr Blood Cancer. 2010;54:311\u20135.","journal-title":"Pediatr Blood Cancer"},{"key":"5198_CR80","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1210\/jc.2003-031965","volume":"89","author":"C Chiellini","year":"2004","unstructured":"Chiellini C, Santini F, Marsili A, Berti P, Bertacca A, Pelosini C, Scartabelli G, Pardini E, Lopez-Soriano J, Centoni R, et al. Serum haptoglobin: a novel marker of adiposity in humans. J Clin Endocrinol Metab. 2004;89:2678\u201383.","journal-title":"J Clin Endocrinol Metab"},{"key":"5198_CR81","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1097\/00000441-196608000-00008","volume":"252","author":"S Krauss","year":"1966","unstructured":"Krauss S, Chrott M, Sarcione EJ. Haptoglobin metabolism in Hodgkin\u2019s disease. The American journal of the medical sciences. 1966;252:184\u201391.","journal-title":"The American journal of the medical sciences"},{"key":"5198_CR82","doi-asserted-by":"crossref","first-page":"8857","DOI":"10.1074\/jbc.M110.150557","volume":"286","author":"O MK","year":"2011","unstructured":"MK O, Park HJ, Kim NH, Park SJ, Park IY, Kim IS. Hypoxia-inducible factor-1 alpha enhances haptoglobin gene expression by improving binding of STAT3 to the promoter. J Biol Chem. 2011;286:8857\u201365.","journal-title":"J Biol Chem"},{"key":"5198_CR83","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1007\/s11695-008-9548-1","volume":"18","author":"J Gomez-Ambrosi","year":"2008","unstructured":"Gomez-Ambrosi J, Rodriguez A, Catalan V, Fruhbeck G. The bone-adipose axis in obesity and weight loss. Obes Surg. 2008;18:1134\u201343.","journal-title":"Obes Surg"},{"key":"5198_CR84","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.bone.2011.06.016","volume":"50","author":"A Krings","year":"2012","unstructured":"Krings A, Rahman S, Huang S, Lu Y, Czernik PJ, Lecka-Czernik B. Bone marrow fat has brown adipose tissue characteristics, which are attenuated with aging and diabetes. Bone. 2012;50:546\u201352.","journal-title":"Bone"},{"key":"5198_CR85","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1210\/jc.2012-3634","volume":"98","author":"PK Fazeli","year":"2013","unstructured":"Fazeli PK, Horowitz MC, MacDougald OA, Scheller EL, Rodeheffer MS, Rosen CJ, Klibanski A. Marrow fat and bone\u2014new perspectives. J Clin Endocrinol Metab. 2013;98:935\u201345.","journal-title":"J Clin Endocrinol Metab"},{"key":"5198_CR86","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/1471-2164-12-212","volume":"12","author":"LF Liu","year":"2011","unstructured":"Liu LF, Shen WJ, Ueno M, Patel S, Kraemer FB. Characterization of age-related gene expression profiling in bone marrow and epididymal adipocytes. BMC Genomics. 2011;12:212.","journal-title":"BMC Genomics"},{"key":"5198_CR87","doi-asserted-by":"crossref","first-page":"e72367","DOI":"10.1371\/journal.pone.0072367","volume":"8","author":"LF Liu","year":"2013","unstructured":"Liu LF, Shen WJ, Ueno M, Patel S, Azhar S, Kraemer FB. Age-related modulation of the effects of obesity on gene expression profiles of mouse bone marrow and epididymal adipocytes. PLoS One. 2013;8:e72367.","journal-title":"PLoS One"},{"key":"5198_CR88","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.exphem.2013.02.005","volume":"41","author":"A Poloni","year":"2013","unstructured":"Poloni A, Maurizi G, Serrani F, Mancini S, Zingaretti MC, Frontini A, Cinti S, Olivieri A, Leoni P. Molecular and functional characterization of human bone marrow adipocytes. Exp Hematol. 2013;41:558\u2013566 e552.","journal-title":"Exp Hematol"},{"key":"5198_CR89","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.exger.2010.09.014","volume":"46","author":"GV Halade","year":"2011","unstructured":"Halade GV, El Jamali A, Williams PJ, Fajardo RJ, Fernandes G. Obesity-mediated inflammatory microenvironment stimulates osteoclastogenesis and bone loss in mice. Exp Gerontol. 2011;46:43\u201352.","journal-title":"Exp Gerontol"},{"key":"5198_CR90","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.bone.2013.06.016","volume":"56","author":"H Sadie-Van Gijsen","year":"2013","unstructured":"Sadie-Van Gijsen H, Hough FS, Ferris WF. Determinants of bone marrow adiposity: the modulation of peroxisome proliferator-activated receptor-gamma2 activity as a central mechanism. Bone. 2013;56:255\u201365.","journal-title":"Bone"},{"key":"5198_CR91","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.bone.2011.06.032","volume":"50","author":"B Lecka-Czernik","year":"2012","unstructured":"Lecka-Czernik B. Marrow fat metabolism is linked to the systemic energy metabolism. Bone. 2012;50:534\u20139.","journal-title":"Bone"},{"key":"5198_CR92","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1200\/JCO.1995.13.2.403","volume":"13","author":"R Munker","year":"1995","unstructured":"Munker R, Hasenclever D, Brosteanu O, Hiller E, Diehl V. Bone marrow involvement in Hodgkin\u2019s disease: an analysis of 135 consecutive cases. German Hodgkin\u2019s Lymphoma Study Group. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1995;13:403\u20139.","journal-title":"Journal of clinical oncology : official journal of the American Society of Clinical Oncology"},{"key":"5198_CR93","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1002\/1097-0142(197610)38:4<1717::AID-CNCR2820380445>3.0.CO;2-9","volume":"38","author":"DI O\u2019Carroll","year":"1976","unstructured":"O\u2019Carroll DI, McKenna RW, Brunning RD. Bone marrow manifestations of Hodgkin\u2019s disease. Cancer. 1976;38:1717\u201328.","journal-title":"Cancer"},{"key":"5198_CR94","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1159\/000337604","volume":"29","author":"RJ Ribeiro","year":"2012","unstructured":"Ribeiro RJ, Monteiro CP, Cunha VF, Azevedo AS, Oliveira MJ, Monteiro R, Fraga AM, Principe P, Lobato C, Lobo F, et al. Tumor cell-educated periprostatic adipose tissue acquires an aggressive cancer-promoting secretory profile. Cellular physiology and biochemistry: international journal of experimental cellular physiology, biochemistry, and pharmacology. 2012;29:233\u201340.","journal-title":"Cellular physiology and biochemistry: international journal of experimental cellular physiology, biochemistry, and pharmacology"},{"key":"5198_CR95","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1158\/0008-5472.CAN-10-3323","volume":"71","author":"B Dirat","year":"2011","unstructured":"Dirat B, Bochet L, Dabek M, Daviaud D, Dauvillier S, Majed B, Wang YY, Meulle A, Salles B, Le Gonidec S, et al. Cancer-associated adipocytes exhibit an activated phenotype and contribute to breast cancer invasion. Cancer Res. 2011;71:2455\u201365.","journal-title":"Cancer Res"},{"key":"5198_CR96","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1038\/nm.2492","volume":"17","author":"KM Nieman","year":"2011","unstructured":"Nieman KM, Kenny HA, Penicka CV, Ladanyi A, Buell-Gutbrod R, Zillhardt MR, Romero IL, Carey MS, Mills GB, Hotamisligil GS, et al. Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth. Nat Med. 2011;17:1498\u2013503.","journal-title":"Nat Med"},{"key":"5198_CR97","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.canlet.2011.07.034","volume":"312","author":"J Lysaght","year":"2011","unstructured":"Lysaght J, van der Stok EP, Allott EH, Casey R, Donohoe CL, Howard JM, McGarrigle SA, Ravi N, Reynolds JV, Pidgeon GP. Pro-inflammatory and tumour proliferative properties of excess visceral adipose tissue. Cancer Lett. 2011;312:62\u201372.","journal-title":"Cancer Lett"},{"key":"5198_CR98","doi-asserted-by":"crossref","first-page":"6408","DOI":"10.1038\/sj.onc.1206737","volume":"22","author":"P Iyengar","year":"2003","unstructured":"Iyengar P, Combs TP, Shah SJ, Gouon-Evans V, Pollard JW, Albanese C, Flanagan L, Tenniswood MP, Guha C, Lisanti MP, et al. Adipocyte-secreted factors synergistically promote mammary tumorigenesis through induction of anti-apoptotic transcriptional programs and proto-oncogene stabilization. Oncogene. 2003;22:6408\u201323.","journal-title":"Oncogene"},{"key":"5198_CR99","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.18632\/oncotarget.1482","volume":"4","author":"MK Herroon","year":"2013","unstructured":"Herroon MK, Rajagurubandara E, Hardaway AL, Powell K, Turchick A, Feldmann D, Podgorski I. Bone marrow adipocytes promote tumor growth in bone via FABP4-dependent mechanisms. Oncotarget. 2013;4:2108\u201323.","journal-title":"Oncotarget"},{"key":"5198_CR100","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/sj.bjc.6603030","volume":"94","author":"MD Brown","year":"2006","unstructured":"Brown MD, Hart CA, Gazi E, Bagley S, Clarke NW. Promotion of prostatic metastatic migration towards human bone marrow stoma by omega 6 and its inhibition by omega 3 PUFAs. Br J Cancer. 2006;94:842\u201353.","journal-title":"Br J Cancer"},{"key":"5198_CR101","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1194\/jlr.M700131-JLR200","volume":"48","author":"E Gazi","year":"2007","unstructured":"Gazi E, Gardner P, Lockyer NP, Hart CA, Brown MD, Clarke NW. Direct evidence of lipid translocation between adipocytes and prostate cancer cells with imaging FTIR microspectroscopy. J Lipid Res. 2007;48:1846\u201356.","journal-title":"J Lipid Res"},{"key":"5198_CR102","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1242\/jcs.079699","volume":"124","author":"CE Lowe","year":"2011","unstructured":"Lowe CE, O\u2019Rahilly S, Rochford JJ. Adipogenesis at a glance. J Cell Sci. 2011;124:2681\u20136.","journal-title":"J Cell Sci"},{"key":"5198_CR103","doi-asserted-by":"crossref","first-page":"6744","DOI":"10.1021\/bi700047a","volume":"46","author":"SD Ayers","year":"2007","unstructured":"Ayers SD, Nedrow KL, Gillilan RE, Noy N. Continuous nucleocytoplasmic shuttling underlies transcriptional activation of PPARgamma by FABP4. Biochemistry. 2007;46:6744\u201352.","journal-title":"Biochemistry"},{"key":"5198_CR104","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1007\/s00262-008-0625-z","volume":"58","author":"TM Garcia-Bates","year":"2009","unstructured":"Garcia-Bates TM, Peslak SA, Baglole CJ, Maggirwar SB, Bernstein SH, Phipps RP. Peroxisome proliferator-activated receptor gamma overexpression and knockdown: impact on human B cell lymphoma proliferation and survival. Cancer immunology, immunotherapy: CII. 2009;58:1071\u201383.","journal-title":"Cancer immunology, immunotherapy: CII"},{"key":"5198_CR105","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/SPC.0b013e32830baea9","volume":"2","author":"C Le Gall","year":"2008","unstructured":"Le Gall C, Bonnelye E, Clezardin P. Cathepsin K inhibitors as treatment of bone metastasis. Current opinion in supportive and palliative care. 2008;2:218\u201322.","journal-title":"Current opinion in supportive and palliative care"},{"key":"5198_CR106","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s12098-010-0019-z","volume":"77","author":"P Singh","year":"2010","unstructured":"Singh P, Bakhshi S. Osseous involvement in pediatric Hodgkin\u2019s lymphoma. Indian J Pediatr. 2010;77:565\u20136.","journal-title":"Indian J Pediatr"},{"key":"5198_CR107","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1007\/s00259-009-1377-5","volume":"37","author":"G Moulin-Romsee","year":"2010","unstructured":"Moulin-Romsee G, Hindie E, Cuenca X, Brice P, Decaudin D, Benamor M, Briere J, Anitei M, Filmont JE, Sibon D, et al. (18)F-FDG PET\/CT bone\/bone marrow findings in Hodgkin\u2019s lymphoma may circumvent the use of bone marrow trephine biopsy at diagnosis staging. Eur J Nucl Med Mol Imaging. 2010;37:1095\u2013105.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"5198_CR108","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1136\/jcp.55.9.693","volume":"55","author":"S Verma","year":"2002","unstructured":"Verma S, Rajaratnam JH, Denton J, Hoyland JA, Byers RJ. Adipocytic proportion of bone marrow is inversely related to bone formation in osteoporosis. J Clin Pathol. 2002;55:693\u20138.","journal-title":"J Clin Pathol"},{"key":"5198_CR109","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1042\/BST0350701","volume":"35","author":"I Podgorski","year":"2007","unstructured":"Podgorski I, Linebaugh BE, Sloane BF. Cathepsin K in the bone microenvironment: link between obesity and prostate cancer? Biochem Soc Trans. 2007;35:701\u20133.","journal-title":"Biochem Soc Trans"},{"key":"5198_CR110","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/jcp.10253","volume":"195","author":"C Chiellini","year":"2003","unstructured":"Chiellini C, Costa M, Novelli SE, Amri EZ, Benzi L, Bertacca A, Cohen P, Del Prato S, Friedman JM, Maffei M. Identification of cathepsin K as a novel marker of adiposity in white adipose tissue. J Cell Physiol. 2003;195:309\u201321.","journal-title":"J Cell Physiol"},{"key":"5198_CR111","doi-asserted-by":"crossref","first-page":"387","DOI":"10.2174\/138161207780162962","volume":"13","author":"O Vasiljeva","year":"2007","unstructured":"Vasiljeva O, Reinheckel T, Peters C, Turk D, Turk V, Turk B. Emerging roles of cysteine cathepsins in disease and their potential as drug targets. Curr Pharm Des. 2007;13:387\u2013403.","journal-title":"Curr Pharm Des"},{"key":"5198_CR112","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1359\/jbmr.2003.18.2.222","volume":"18","author":"KD Brubaker","year":"2003","unstructured":"Brubaker KD, Vessella RL, True LD, Thomas R, Corey E. Cathepsin K mRNA and protein expression in prostate cancer progression. Journal of bone and mineral research: the official journal of the American Society for Bone and Mineral Research. 2003;18:222\u201330.","journal-title":"Journal of bone and mineral research: the official journal of the American Society for Bone and Mineral Research"},{"key":"5198_CR113","doi-asserted-by":"crossref","first-page":"9894","DOI":"10.1158\/0008-5472.CAN-06-3940","volume":"67","author":"C Le Gall","year":"2007","unstructured":"Le Gall C, Bellahcene A, Bonnelye E, Gasser JA, Castronovo V, Green J, Zimmermann J, Clezardin P. A cathepsin K inhibitor reduces breast cancer induced osteolysis and skeletal tumor burden. Cancer Res. 2007;67:9894\u2013902.","journal-title":"Cancer Res"},{"key":"5198_CR114","doi-asserted-by":"crossref","first-page":"48745","DOI":"10.1074\/jbc.M309193200","volume":"278","author":"K Henriksen","year":"2003","unstructured":"Henriksen K, Karsdal M, Delaisse JM, Engsig MT. RANKL and vascular endothelial growth factor (VEGF) induce osteoclast chemotaxis through an ERK1\/2-dependent mechanism. J Biol Chem. 2003;278:48745\u201353.","journal-title":"J Biol Chem"},{"key":"5198_CR115","doi-asserted-by":"crossref","first-page":"558","DOI":"10.3109\/10428194.2013.813629","volume":"55","author":"GS Dimtsas","year":"2014","unstructured":"Dimtsas GS, Georgiadi EC, Karakitsos P, Vassilakopoulos TP, Thymara I, Korkolopoulou P, Patsouris E, Kittas C, Doussis-Anagnostopoulou IA. Prognostic significance of immunohistochemical expression of the angiogenic molecules vascular endothelial growth factor-a, vascular endothelial growth factor receptor-1 and vascular endothelial growth factor receptor-2 in patients with classical Hodgkin lymphoma. Leukemia & lymphoma. 2014;55:558\u201364.","journal-title":"Leukemia & lymphoma"},{"key":"5198_CR116","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/path.1151","volume":"197","author":"IA Doussis-Anagnostopoulou","year":"2002","unstructured":"Doussis-Anagnostopoulou IA, Talks KL, Turley H, Debnam P, Tan DC, Mariatos G, Gorgoulis V, Kittas C, Gatter KC. Vascular endothelial growth factor (VEGF) is expressed by neoplastic Hodgkin-Reed-Sternberg cells in Hodgkin\u2019s disease. J Pathol. 2002;197:677\u201383.","journal-title":"J Pathol"},{"key":"5198_CR117","doi-asserted-by":"crossref","first-page":"291","DOI":"10.3109\/10799893.2013.828070","volume":"33","author":"EL Pacheco-Pantoja","year":"2013","unstructured":"Pacheco-Pantoja EL, Waring VJ, Wilson PJ, Fraser WD, Gallagher JA. Adiponectin receptors are present in RANK-L-induced multinucleated osteoclast-like cells. J Recept Signal Transduct Res. 2013;33:291\u20137.","journal-title":"J Recept Signal Transduct Res"},{"key":"5198_CR118","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1172\/JCI0214506","volume":"109","author":"T Yokota","year":"2002","unstructured":"Yokota T, Meka CS, Medina KL, Igarashi H, Comp PC, Takahashi M, Nishida M, Oritani K, Miyagawa J, Funahashi T, et al. Paracrine regulation of fat cell formation in bone marrow cultures via adiponectin and prostaglandins. J Clin Invest. 2002;109:1303\u201310.","journal-title":"J Clin Invest"},{"key":"5198_CR119","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.beem.2013.11.005","volume":"28","author":"L Hebbard","year":"2014","unstructured":"Hebbard L, Ranscht B. Multifaceted roles of adiponectin in cancer. Best Pract Res Clin Endocrinol Metab. 2014;28:59\u201369.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"5198_CR120","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2220\/biomedres.32.37","volume":"32","author":"H Goto","year":"2011","unstructured":"Goto H, Osaki M, Fukushima T, Sakamoto K, Hozumi A, Baba H, Shindo H. Human bone marrow adipocytes support dexamethasone-induced osteoclast differentiation and function through RANKL expression. Biomedical research (Tokyo, Japan). 2011;32:37\u201344.","journal-title":"Biomedical research (Tokyo, Japan)"},{"key":"5198_CR121","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1182\/blood.V98.9.2784","volume":"98","author":"P Fiumara","year":"2001","unstructured":"Fiumara P, Snell V, Li Y, Mukhopadhyay A, Younes M, Gillenwater AM, Cabanillas F, Aggarwal BB, Younes A. Functional expression of receptor activator of nuclear factor kappaB in Hodgkin disease cell lines. Blood. 2001;98:2784\u201390.","journal-title":"Blood"},{"key":"5198_CR122","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1096\/fasebj.12.9.747","volume":"12","author":"P Laharrague","year":"1998","unstructured":"Laharrague P, Larrouy D, Fontanilles AM, Truel N, Campfield A, Tenenbaum R, Galitzky J, Corberand JX, Penicaud L, Casteilla L. High expression of leptin by human bone marrow adipocytes in primary culture. FASEB journal: official publication of the Federation of American Societies for Experimental Biology. 1998;12:747\u201352.","journal-title":"FASEB journal: official publication of the Federation of American Societies for Experimental Biology"},{"key":"5198_CR123","first-page":"634","volume":"11","author":"P Laharrague","year":"2000","unstructured":"Laharrague P, Fontanilles AM, Tkaczuk J, Corberand JX, Penicaud L, Casteilla L. Inflammatory\/haematopoietic cytokine production by human bone marrow adipocytes. Eur Cytokine Netw. 2000;11:634\u20139.","journal-title":"Eur Cytokine Netw"},{"key":"5198_CR124","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1055\/s-2007-978658","volume":"32","author":"P Laharrague","year":"2000","unstructured":"Laharrague P, Truel N, Fontanilles AM, Corberand JX, Penicaud L, Casteilla L. Regulation by cytokines of leptin expression in human bone marrow adipocytes. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme. 2000;32:381\u20135.","journal-title":"Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme"},{"key":"5198_CR125","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1158\/1078-0432.CCR-13-3007","volume":"20","author":"Y Hao","year":"2014","unstructured":"Hao Y, Chapuy B, Monti S, Sun HH, Rodig SJ, Shipp MA. Selective JAK2 inhibition specifically decreases Hodgkin lymphoma and mediastinal large B-cell lymphoma growth in vitro and in vivo. Clinical cancer research: an official journal of the American Association for Cancer Research. 2014;20:2674\u201383.","journal-title":"Clinical cancer research: an official journal of the American Association for Cancer Research"},{"key":"5198_CR126","doi-asserted-by":"crossref","first-page":"C1481","DOI":"10.1152\/ajpcell.00062.2007","volume":"293","author":"ML Gruen","year":"2007","unstructured":"Gruen ML, Hao M, Piston DW, Hasty AH. Leptin requires canonical migratory signaling pathways for induction of monocyte and macrophage chemotaxis. American journal of physiology Cell physiology. 2007;293:C1481\u20138.","journal-title":"American journal of physiology Cell physiology"},{"key":"5198_CR127","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1158\/0008-5472.CAN-06-3075","volume":"67","author":"NK Saxena","year":"2007","unstructured":"Saxena NK, Sharma D, Ding X, Lin S, Marra F, Merlin D, Anania FA. Concomitant activation of the JAK\/STAT, PI3K\/AKT, and ERK signaling is involved in leptin-mediated promotion of invasion and migration of hepatocellular carcinoma cells. Cancer Res. 2007;67:2497\u2013507.","journal-title":"Cancer Res"},{"key":"5198_CR128","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1002\/pbc.22722","volume":"55","author":"FV Okur","year":"2010","unstructured":"Okur FV, Karadeniz C, Buyukpamukcu M, Oguz A, Yucel A, Cinaz P, Emir S, Varan A. Clinical significance of serum vascular endothelial growth factor, endostatin, and leptin levels in children with lymphoma. Pediatr Blood Cancer. 2010;55:1272\u20137.","journal-title":"Pediatr Blood Cancer"},{"key":"5198_CR129","first-page":"241","volume":"28","author":"GE Pamuk","year":"2006","unstructured":"Pamuk GE, Demir M, Harmandar F, Yesil Y, Turgut B, Vural O. Leptin and resistin levels in serum of patients with hematologic malignancies: correlation with clinical characteristics. Exp Oncol. 2006;28:241\u20134.","journal-title":"Exp Oncol"},{"key":"5198_CR130","doi-asserted-by":"crossref","first-page":"6812","DOI":"10.1158\/1078-0432.CCR-13-1879","volume":"19","author":"PR Marri","year":"2013","unstructured":"Marri PR, Hodge LS, Maurer MJ, Ziesmer SC, Slager SL, Habermann TM, Link BK, Cerhan JR, Novak AJ, Ansell SM. Prognostic significance of pretreatment serum cytokines in classical Hodgkin lymphoma. Clin Cancer Res. 2013;19:6812\u20139.","journal-title":"Clin Cancer Res"},{"key":"5198_CR131","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1046\/j.1365-2141.2002.03575.x","volume":"118","author":"GM Reynolds","year":"2002","unstructured":"Reynolds GM, Billingham LJ, Gray LJ, Flavell JR, Najafipour S, Crocker J, Nelson P, Young LS, Murray PG. Interleukin 6 expression by Hodgkin\/Reed-Sternberg cells is associated with the presence of \u2018B\u2019 symptoms and failure to achieve complete remission in patients with advanced Hodgkin\u2019s disease. Br J Haematol. 2002;118:195\u2013201.","journal-title":"Br J Haematol"},{"key":"5198_CR132","first-page":"518","volume":"13","author":"F Montanari","year":"2015","unstructured":"Montanari F, Diefenbach CS. Hodgkin lymphoma: targeting the tumor microenvironment as a therapeutic strategy. Clinical advances in hematology & oncology: H&O. 2015;13:518\u201324.","journal-title":"Clinical advances in hematology & oncology: H&O"},{"key":"5198_CR133","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/nature05483","volume":"444","author":"ED Rosen","year":"2006","unstructured":"Rosen ED, Spiegelman BM. Adipocytes as regulators of energy balance and glucose homeostasis. Nature. 2006;444:847\u201353.","journal-title":"Nature"},{"key":"5198_CR134","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/nrendo.2014.94","volume":"10","author":"J Park","year":"2014","unstructured":"Park J, Morley TS, Kim M, Clegg DJ, Scherer PE. Obesity and cancer\u2014mechanisms underlying tumour progression and recurrence. Nat Rev Endocrinol. 2014;10:455\u201365.","journal-title":"Nat Rev Endocrinol"},{"key":"5198_CR135","doi-asserted-by":"crossref","first-page":"3568","DOI":"10.1200\/JCO.2014.58.4680","volume":"32","author":"JA Ligibel","year":"2014","unstructured":"Ligibel JA, Alfano CM, Courneya KS, Demark-Wahnefried W, Burger RA, Chlebowski RT, Fabian CJ, Gucalp A, Hershman DL, Hudson MM, et al. American Society of Clinical Oncology position statement on obesity and cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2014;32:3568\u201374.","journal-title":"Journal of clinical oncology : official journal of the American Society of Clinical Oncology"}],"container-title":["Tumor Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-016-5198-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13277-016-5198-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-016-5198-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T06:21:39Z","timestamp":1749018099000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13277-016-5198-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,27]]},"references-count":135,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["5198"],"URL":"https:\/\/doi.org\/10.1007\/s13277-016-5198-4","relation":{},"ISSN":["1010-4283","1423-0380"],"issn-type":[{"type":"print","value":"1010-4283"},{"type":"electronic","value":"1423-0380"}],"subject":[],"published":{"date-parts":[[2016,7,27]]}}}